Cann Group Ltd. · ASX:CAN

Cann — FY2023 Earnings Presentation

19 slides from Cann's earnings presentation, Aug 28, 2023

  1. Slide 1: ASX Announcement: Investor presentation

    ASX ANNOUNCEMENT 28 August 2023 Investor presentation 28 August 2023 – Cann Group Limited (ASX: CAN) (Cann or the Company) is pleased to invite shareholders, investors and interested parties to an investor update webinar and Q&A with CEO, Peter Koetsier, to outline the Company’s FY23 financial resul

  2. Slide 2: Growing a better life.

    Growing a better life. Investor presentation | 28 August 2023

  3. Slide 3: Disclaimer: Important notice

    Disclaimer: Important notice This presentation (Presentation) has been prepared by Cann Group Limited (ABN 25 603 949 739) (Cann). Summary information This Presentation contains summary information about Cann and its activities which is current as at the date of this Presentation. The information pr

  4. Slide 4: Agenda

    Agenda 1 FY 2023 Highlights 2 Operational Review 3 Financial Results 4 Mildura Update 5 Strategy & Outlook for FY 2024 6 Appendix

  5. Slide 5: FY 2023 Highlights

    FY 2023 Highlights Substantial growth in Doubled sales to production, quality $13.78 million and range May 2023, planted Cann signs double the crop area significant variation of previous harvests with key customer Cann successfully raises $8.18 million Sale of Southern facility via SPP (Dec 2022) Ca

  6. Slide 6: Commercial Operations: Sales more than doubled to $13.78 million

    Commercial Operations: Sales more than doubled to $13.78 million • Fulfilment of repeat orders from large B2B customers REVENUE BY PRODUCT COMPARISON TO PRIOR YEAR has facilitated rapid growth 8000000 • Strong market demand saw dried flower products 7000000 revenue increase by 503% on FY22 • 80,165

  7. Slide 7: Mildura Update

    Mildura Update • Mildura facility progressed from concept, through construction and development phase, to now focus on scale and quality of production • Cann planted the largest commercial crop area in the Company’s history in May 23 • On track to reach a 9-tonne annualised rate in the second half o

  8. Slide 8: Cann's Evolving Focus

    Cann’s Evolving Focus • The benchmark in breeding, cultivating, manufacturing and supplying medicinal cannabis in Australia and globally • Pursuing a full-service business model with supply agreements, collaboration agreements, resources and capabilities • As we increase production, we expect to cre

  9. Slide 9: Financial Results

    Financial Results CANN GROUP LIMITED

  10. Slide 10: Financial Results

    Financial Results FY23 FY22 • Sales revenue was $13.78m representing an increase Mvt % Mvt of 115% on the prior financial year. 000's 000's • Total revenue for the year of $21.68m. Revenue from operating activities 13,777 6,411 7,366 115% • R&D Tax Incentive refund of $3.4m accrued for FY23. Other i

  11. Slide 11: The Evolution of Cann's Focus

    The Evolution of Cann’s Focus 2017-2021 Late 2021 – Early 2022 – First half Second half Mid 2022 End 2022 2023 2023 & beyond The vision Laying the foundation Growing into the Scaling up Continued growth • Project management • Practical completion facility • Increasing all areas to • Reach full capac

  12. Slide 12: Leadership Update

    Leadership Update • Considerable change in leadership in the last 12 months • Experience and skill of new personnel aligned with needs of the Company in its current growth phase • Board and management succession and renewal process synchronises with the transition of Cann’s business to a more commer

  13. Slide 13: Investment Case | Key Messages

    Investment Case | Key Messages 1. First mover and competitive advantage with state of the art, fully licensed facility able to scale quality supply 2. Substantial unmet demand for reliable, locally produced quality product 3. Executing strategy with business shifting to operational expenditure from

  14. Slide 14: Strategic Outlook for FY 2024

    Strategic Outlook for FY 2024 In FY 2024, Cann’s growth strategy will focus on three key areas: Progressing the scale and Extending portfolio range to Continuing our path towards quality of production meet market demands EBITDA profitability Cann Group Limited | Annual Report FY 2023 | Investor pres

  15. Slide 15: Q&A

    Q&A

  16. Slide 16: Contact

    Contact Peter Koetsier Chief Executive Officer peter.koetsier@canngrouplimited.com Deborah Ambrosini Chief Financial Officer and Company Secretary deborah.ambrosini@canngrouplimited.com Jackson Paine Corporate Communications Manager jackson.paine@canngrouplimited.com canngrouplimited.com | +61 3 909

  17. Slide 17: Appendix A | Consolidated Statement of Profit & Loss and Other Income

    Appendix A | Consolidated Statement of Profit & Loss and Other Income For year ended 30 June 2023 Cann Group Limited | Annual Report FY 2023 | Investor presentation 16

  18. Slide 18: Appendix C | Consolidated Statement of Financial Position

    Appendix C | Consolidated Statement of Financial Position For year ended 30 June 2023 Cann Group Limited | Annual Report FY 2023 | Investor presentation 17

  19. Slide 19: Appendix B | Consolidated Statement of Cash Flows

    Appendix B | Consolidated Statement of Cash Flows For year ended 30 June 2023 Cann Group Limited | Annual Report FY 2023 | Investor presentation 18

Cann Group — FY2023 Earnings Presentation on 6ix